111 Inc (YI)
1.14
+0.01
(+0.88%)
USD |
NASDAQ |
May 09, 16:00
111 Enterprise Value: 168.35M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 168.35M |
| May 08, 2024 | 167.51M |
| May 07, 2024 | 170.87M |
| May 06, 2024 | 170.03M |
| May 03, 2024 | 169.19M |
| May 02, 2024 | 166.67M |
| May 01, 2024 | 160.79M |
| April 30, 2024 | 159.95M |
| April 29, 2024 | 162.05M |
| April 26, 2024 | 159.11M |
| April 25, 2024 | 157.43M |
| April 24, 2024 | 160.79M |
| April 23, 2024 | 164.15M |
| April 22, 2024 | 161.63M |
| April 19, 2024 | 158.27M |
| April 18, 2024 | 156.59M |
| April 17, 2024 | 154.08M |
| April 16, 2024 | 156.59M |
| April 15, 2024 | 158.27M |
| April 12, 2024 | 164.99M |
| April 11, 2024 | 162.47M |
| April 10, 2024 | 167.51M |
| April 09, 2024 | 169.19M |
| April 08, 2024 | 167.51M |
| April 05, 2024 | 166.67M |
| Date | Value |
|---|---|
| April 04, 2024 | 168.35M |
| April 03, 2024 | 167.09M |
| April 02, 2024 | 170.03M |
| April 01, 2024 | 175.91M |
| March 28, 2024 | 170.03M |
| March 27, 2024 | 157.43M |
| March 26, 2024 | 159.95M |
| March 25, 2024 | 164.15M |
| March 22, 2024 | 161.63M |
| March 21, 2024 | 175.07M |
| March 20, 2024 | 201.10M |
| March 19, 2024 | 197.74M |
| March 18, 2024 | 197.74M |
| March 15, 2024 | 200.26M |
| March 14, 2024 | 197.74M |
| March 13, 2024 | 197.74M |
| March 12, 2024 | 191.86M |
| March 11, 2024 | 188.50M |
| March 08, 2024 | 186.72M |
| March 07, 2024 | 185.99M |
| March 06, 2024 | 189.34M |
| March 05, 2024 | 186.82M |
| March 04, 2024 | 185.99M |
| March 01, 2024 | 188.50M |
| February 29, 2024 | 187.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
57.61M
Minimum
Sep 06 2019
2.216B
Maximum
Feb 16 2021
409.71M
Average
327.07M
Median
Aug 25 2023
Enterprise Value Benchmarks
| Concord Medical Services Holdings Ltd | 993.05M |
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 23.28M |
| Zai Lab Ltd | 1.473B |
| ASLAN Pharmaceuticals Ltd | 14.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.23M |
| Revenue (Quarterly) | 570.81M |
| Total Expenses (Quarterly) | 599.50M |
| EPS Diluted (Quarterly) | -0.3445 |
| Gross Profit Margin (Quarterly) | 5.21% |
| Profit Margin (Quarterly) | -5.12% |
| Earnings Yield | -56.94% |
| Normalized Earnings Yield | -56.96 |